The value of contrast-enhanced ultrasonography to detect the sacroiliac joint for predicting relapse after discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis | Zendy

Jiayu Ren | Zendy; Jiaan Zhu | Zendy; Diancheng Li | Zendy; Wenxue Li | Zendy; Fang Liu | Zendy

Open Access

The value of contrast-enhanced ultrasonography to detect the sacroiliac joint for predicting relapse after discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis

Author(s) -

Jiayu Ren,

Jiaan Zhu,

Diancheng Li,

Wenxue Li,

Fang Liu

Publication year - 2019

Publication title -

quantitative imaging in medicine and surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.766

H-Index - 21

eISSN - 2223-4292

pISSN - 2223-4306

DOI - 10.21037/qims.2019.06.06

Subject(s) - medicine , ankylosing spondylitis , basdai , discontinuation , sacroiliac joint , spondylitis , radiology , tumor necrosis factor alpha , rheumatoid arthritis , psoriatic arthritis

Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by high relapse. Therefore, the present study aimed to investigate the ultrasonographic features of contrast-enhanced ultrasonography (CEUS) in the sacroiliac joint (SIJ) in patients with AS in remission after discontinuation of anti-tumor necrosis factor (TNF) therapy, and also examined the role of CEUS in predicting relapse.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research